Investigation Overview
San Diego, Nov. 18, 2011 (Shareholders Foundation) -- An investigation on behalf of investors in shares of Abbott Laboratories (NYSE: ABT) over breaches of fiduciary duty and other violations of the law by certain officers and directors at Abbott Laboratories was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Abbott ...
You must register (for free) or login to view the entire investigation.